View this email in your browser
Share Share
Tweet Tweet
Forward Forward

Update for Primary Care

Our latest primary care news and guidance.
January 2022
NewsInto practice Get involved | Announcements 


Generic illustration of magnifying glass

We’re changing the way we evaluate medicines and health technologies

Following extensive consultation with health system partners, industry, healthcare professionals, academia and patients, we’re changing how topics are chosen (topic selection), the steps and stages in each evaluation (processes), and how evidence is collected and considered (methods) when assessing new medicines and other health technology products intended for use in the NHS. The changes will give patients earlier access to innovative new treatments by allowing greater flexibility over decisions about value for money and consideration of a broader evidence base. This new approach will come into effect for new submissions to NICE from 1 February.

Girl during session with psychotherapist

Self-harm is everyone’s business

Our new draft guideline on self-harm, the first for 11 years, sets out the responsibilities of non-specialists in mental health. This includes health and social care professionals working in primary care. The guideline calls for non-specialists, who have provided initial care, to organise a comprehensive psychosocial assessment at the earliest opportunity after an episode of self-harm. This assessment should be carried out by a specialist mental health professional.

public consultation is open until Tuesday 1 March 2022.

Offer PrEP to people at high risk of HIV

Our latest draft guideline on reducing sexually transmitted infections recommends that people at the highest risk of catching HIV should be offered Pre Exposure Prophylaxis (PrEP) routinely. This includes:

  • HIV negative men who have condomless sex with other men
  • HIV-negative heterosexual men and women having condomless sex with partners who are HIV positive
  • HIV-negative trans women who are identified as being at elevated risk of HIV acquisition through condomless sex.

Only specialist sexual health services are authorised to prescribe PrEP in the NHS in England. However, our guideline committee has recommended awareness should be raised among health professionals who work in primary care, community settings and gender identity clinics about which groups of people are eligible for PrEP.

New peanut allergy treatment to benefit children and young people

We’ve recommended Palforzia, a new treatment which can help build up tolerance to peanut, in new draft guidance. It works by gradually increasing the body’s ability to tolerate small amounts of peanut and can help reduce the severity of allergic reactions. When people start taking Palforzia, they need to attend a clinic which is able to treat anaphylaxis. If successful, people will then be able to up their dosing but will still need to attend a clinic each time the dose is raised.

Catch up on all our latest news articles
NICE Talks logo

Changes to our methods and processes for health technology evaluation

In this episode of our NICE Talks podcast, we speak with Helen Knight, programme director in NICE’s Centre for Health Technology Evaluation, and Dr Jane Adam, chair of one of our independent appraisal committees. They discuss what our changes mean for patients, the NHS and industry.

Into practice

Progress in improving arthritis treatment

Our latest impact report focuses on the treatment of arthritis. The report shows how reductions in the price of some medicines for arthritis have allowed us to recommend expanded access to transformative treatments. The report also highlights progress in reducing the time between referral and starting treatment for people with inflammatory arthritis.

Read arthritis impact report

Get involved

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We’re looking for health and social care professionals, including a pharmacist, GP and practice nurse to join our:

Our guidance and quality standards are developed by independent committees. Join us and have an active role in producing a guideline or quality standard.
See all our committee vacancies

Observe a meeting

We’re currently holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Friday 18 February 2022 – Medical technologies advisory committee
    Registration opens Friday 28 January and closes Friday 11 February 2022.
    Agenda and register
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all our public meetings


Withdrawal of key therapeutic topics

We are withdrawing our medicines optimisation: key therapeutic topics on 9 February 2022.

This decision has been taken after reviewing the wide range of services we currently provide, so that we can focus on delivering the priorities outlined in our 5-year strategy.

If you have any queries, please contact


unsubscribe from this list